Company · CIK 0001535955 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Lipocine Inc. · LPCN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 AForm 4 → | Aug 7, 4:11 pm EDT | Michael GrissingerDirector | 2,000 | $2.11 | $4,220 | 2,000 | — | late |
| Jun 29, 2026 AForm 4 → | Jun 30, 7:31 pm EDT | Mahesh V. PatelChief Executive Officer, Director | 52,781 | $2.49 | $131,425 | 227,214 | — |